Fate Therapeutics Inc (FATE)

[jondoeuk]

Upcoming at EULAR:

Safety and Efficacy of an Off-the-Shelf Anti-CD19 CAR T-Cell Therapy With Reduced Conditioning in SLE: A Phase 1 Study Supporting Same-Day Discharge https://pag.virtual-meeting.org/EULAR/eular26/en-GB/pag/presentation/24303


Off-the-Shelf Dual-CAR T-Cell Therapy: Targeting B and T Cells in Autoimmune Disease Without Preconditioning https://pag.virtual-meeting.org/EULAR/eular26/en-GB/pag/presentation/24009